Company
Zymergen Inc. (0001645842)
Standardized SEC financial data for Zymergen Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001645842 · Services-Commercial Physical & Biological Research.
Gross margin
-316.4%
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
26.0%
Return on equity
-88.6%
ROIC
-504.9%
Free cash flow
-$335.9M
Debt / equity
0.11×
Ratios for fiscal year 2021, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
| Revenue | $15.4M | $13.3M | $16.7M |
| Cost of revenue | $102.6M | $84.8M | $69.7M |
| Gross profit | -$87.2M | -$71.5M |
Balance sheet
| USD | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|
| Cash & equivalents | $343.9M | $163.0M | $219.8M | $398.1M |
| Inventory | — | — | $5.0M | $6.0M |
Cash flow
| USD | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
| Operating cash flow | -$195.6M | -$223.2M | -$302.5M |
| Capital expenditures | $22.9M | $17.2M | $33.4M |
| Free cash flow | -$218.4M | -$240.4M |
Get 0001645842 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001645842/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001645842/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"